{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:38:05Z","timestamp":1785753485299,"version":"3.56.0"},"reference-count":254,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft","award":["B15"],"award-info":[{"award-number":["B15"]}]},{"name":"Deutsche Forschungsgemeinschaft","award":["B17"],"award-info":[{"award-number":["B17"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatocytes exert pivotal roles in metabolism, protein synthesis and detoxification. Non-parenchymal liver cells (NPCs), largely comprising macrophages, dendritic cells, hepatic stellate cells and liver sinusoidal cells (LSECs), serve to induce immunological tolerance. Therefore, the liver is an important target for therapeutic approaches, in case of both (inflammatory) metabolic diseases and immunological disorders. This review aims to summarize current preclinical nanodrug-based approaches for the treatment of liver disorders. So far, nano-vaccines that aim to induce hepatitis virus-specific immune responses and nanoformulated adjuvants to overcome the default tolerogenic state of liver NPCs for the treatment of chronic hepatitis have been tested. Moreover, liver cancer may be treated using nanodrugs which specifically target and kill tumor cells. Alternatively, nanodrugs may target and reprogram or deplete immunosuppressive cells of the tumor microenvironment, such as tumor-associated macrophages. Here, combination therapies have been demonstrated to yield synergistic effects. In the case of autoimmune hepatitis and other inflammatory liver diseases, anti-inflammatory agents can be encapsulated into nanoparticles to dampen inflammatory processes specifically in the liver. Finally, the tolerance-promoting activity especially of LSECs has been exploited to induce antigen-specific tolerance for the treatment of allergic and autoimmune diseases.<\/jats:p>","DOI":"10.3390\/ijms241411869","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T01:21:27Z","timestamp":1690248087000},"page":"11869","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications"],"prefix":"10.3390","volume":"24","author":[{"given":"Leonard","family":"Kaps","sequence":"first","affiliation":[{"name":"I. Department of Medicine, University Medical Center Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2848-4679","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Limeres","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, University Medical Center, Langenbeckstrasse 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Schneider","sequence":"additional","affiliation":[{"name":"I. Department of Medicine, University Medical Center Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Svensson","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, University Medical Center, Langenbeckstrasse 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2501-8149","authenticated-orcid":false,"given":"Yanira","family":"Zeyn","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Medical Center Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9211-2513","authenticated-orcid":false,"given":"Silvia","family":"Fraude","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, University Medical Center, Langenbeckstrasse 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3144-8794","authenticated-orcid":false,"given":"Maximiliano L.","family":"Cacicedo","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, University Medical Center, Langenbeckstrasse 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Galle","sequence":"additional","affiliation":[{"name":"I. Department of Medicine, University Medical Center Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Gehring","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, University Medical Center, Langenbeckstrasse 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bros","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Medical Center Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9374896","DOI":"10.1155\/2020\/9374896","article-title":"In Search of Zonation Markers to Identify Liver Functional Disorders","volume":"2020","author":"Yang","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rizzo, G.E.M., Cabibbo, G., and Crax\u00ec, A. (2022). Hepatitis B Virus-Associated Hepatocellular Carcinoma. Viruses, 14.","DOI":"10.3390\/v14050986"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/17474124.2021.1946393","article-title":"Metabolic disorders and the risk of cholangiocarcinoma","volume":"15","author":"Ghidini","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","article-title":"Liver metastases","volume":"7","author":"Tsilimigras","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.3389\/fimmu.2019.02525","article-title":"Liver-Mediated Adaptive Immune Tolerance","volume":"10","author":"Zheng","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijpharm.2019.03.011","article-title":"Natural biodegradable polymers based nano-formulations for drug delivery: A review","volume":"561","author":"George","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e2106456","DOI":"10.1002\/adma.202106456","article-title":"Understanding Nanomaterial-Liver Interactions to Facilitate the Development of Safer Nanoapplications","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"key":"ref_10","first-page":"79","article-title":"Lipid-based nanoparticle technologies for liver targeting","volume":"154\u2013155","author":"Pauli","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"735573","DOI":"10.3389\/fphys.2021.735573","article-title":"The whole Story About Fenestrations in LSEC","volume":"12","author":"Szafranska","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2353\/ajpath.2010.090136","article-title":"The role of liver sinusoidal cells in hepatocyte-directed gene transfer","volume":"176","author":"Jacobs","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.3389\/fimmu.2019.03112","article-title":"Macrophage Phenotype and Function in Liver Disorder","volume":"10","author":"Dou","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bhandari, S., Li, R., Sim\u00f3n-Santamar\u00eda, J., McCourt, P., Johansen, S.D., Smedsr\u00f8d, B., Martinez-Zubiaurre, I., and S\u00f8rensen, K.K. (2020). Transcriptome and proteome profiling reveal complementary scavenger and immune features of rat liver sinusoidal endothelial cells and liver macrophages. BMC Mol. Cell Biol., 21.","DOI":"10.1186\/s12860-020-00331-9"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"757469","DOI":"10.3389\/fphys.2021.757469","article-title":"The Scavenger Function of Liver Sinusoidal Endothelial Cells in Health and Disease","volume":"12","author":"Bhandari","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Adepu, S., and Ramakrishna, S. (2021). Controlled Drug Delivery Systems: Current Status and Future Directions. Molecules, 26.","DOI":"10.3390\/molecules26195905"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100056","DOI":"10.1016\/j.mtbio.2020.100056","article-title":"Rational design and latest advances of codelivery systems for cancer therapy","volume":"7","author":"Meng","year":"2020","journal-title":"Mater. Today Bio"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"855794","DOI":"10.3389\/fonc.2022.855794","article-title":"Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma","volume":"12","author":"Homan","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2018.01.033","article-title":"Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors","volume":"68","author":"Michot","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1042125","DOI":"10.3389\/fonc.2022.1042125","article-title":"Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy","volume":"12","author":"Katopodi","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hep.32314","article-title":"Getting to HBV cure: The promising paths forward","volume":"76","author":"Fung","year":"2022","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2217\/nnm-2016-0064","article-title":"Novel strategies in vaccine design: Can nanocapsules help prevent and treat hepatitis B?","volume":"12","author":"Gehring","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Medina-Montano, C., Rivero Berti, I., Gambaro, R.C., Limeres, M.J., Svensson, M., Padula, G., Chain, C.Y., Cisneros, J.S., Castro, G.R., and Grabbe, S. (2022). Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081611"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1177\/0885328219836540","article-title":"Doxorubicin-loaded Fe3O4-ZIF-8 nano-composites for hepatocellular carcinoma therapy","volume":"33","author":"Cheng","year":"2019","journal-title":"J. Biomater. Appl."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.2147\/IJN.S363456","article-title":"Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review","volume":"17","author":"Huang","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s12951-021-01101-1","article-title":"Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma","volume":"19","author":"Xu","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/hep.23043","article-title":"Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver","volume":"50","author":"Breous","year":"2009","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/hep.23191","article-title":"Priming of CD4+ T cells by liver sinusoidal endothelial cells induces CD25low forkhead box protein 3-regulatory T cells suppressing autoimmune hepatitis","volume":"50","author":"Kruse","year":"2009","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.4049\/jimmunol.0803404","article-title":"Human liver dendritic cells promote T cell hyporesponsiveness","volume":"182","author":"Bamboat","year":"2009","journal-title":"J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1021\/acsnano.0c09206","article-title":"Antigen- and Epitope-Delivering Nanoparticles Targeting Liver Induce Comparable Immunotolerance in Allergic Airway Disease and Anaphylaxis as Nanoparticle-Delivering Pharmaceuticals","volume":"15","author":"Liu","year":"2021","journal-title":"ACS Nano"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/imm.13298","article-title":"Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis","volume":"162","author":"Carambia","year":"2021","journal-title":"Immunology"},{"key":"ref_34","unstructured":"Mehta, P., and Reddivari, A.K.R. (2022). StatPearls, StatPearls Publishing."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","article-title":"Hepatitis B virus (HBV) and autoimmune disease","volume":"34","author":"Maya","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Buschow, S.I., and Jansen, D. (2021). CD4+ T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy. Cells, 10.","DOI":"10.3390\/cells10051114"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"Maini","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fphar.2014.00167","article-title":"The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies","volume":"5","author":"Xu","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101191","DOI":"10.1016\/j.mam.2023.101191","article-title":"Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies","volume":"92","author":"Lurje","year":"2023","journal-title":"Mol. Asp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/his.12957","article-title":"Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: Implications for liver biopsy interpretation","volume":"68","author":"Quaglia","year":"2016","journal-title":"Histopathology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII\u2014Renewing consensus in portal hypertension","volume":"76","author":"Bosch","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_42","unstructured":"Holmes, K.K., Bertozzi, S., Bloom, B.R., and Jha, P. (2017). Major Infectious Diseases, The International Bank for Reconstruction and Development, The World Bank."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"104925","DOI":"10.1016\/j.antiviral.2020.104925","article-title":"Hepatitis B virus biology and life cycle","volume":"182","author":"Tsukuda","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"652962","DOI":"10.3389\/fmicb.2021.652962","article-title":"Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin","volume":"12","author":"Netter","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3748\/wjg.v27.i16.1691","article-title":"From hepatitis A to E: A critical review of viral hepatitis","volume":"27","author":"Castaneda","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Kl\u00f6hn, M., Schrader, J.A., Br\u00fcggemann, Y., Todt, D., and Steinmann, E. (2021). Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13225867"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejphar.2018.06.030","article-title":"Strategies for the treatment of HBV\/HDV","volume":"833","author":"Krause","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"(2017). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol., 67, 370\u2013398.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"(2020). EASL recommendations on treatment of hepatitis C: Final update of the series(\u2606). J. Hepatol., 73, 1170\u20131218.","DOI":"10.1016\/j.jhep.2020.08.018"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.4103\/0255-0857.150908","article-title":"Prevalence of Hepatitis A virus (HAV) and Hepatitis E virus (HEV) in the patients presenting with acute viral hepatitis","volume":"33","author":"Joon","year":"2015","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"a036855","DOI":"10.1101\/cshperspect.a036855","article-title":"Interferon-Free Hepatitis C Virus Therapy","volume":"10","author":"Pawlotsky","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijbiomac.2022.03.026","article-title":"Drug delivery of sofosbuvir drug capsulated with the \u03b2-cyclodextrin basket loaded on chitosan nanoparticle surface for anti-hepatitis C virus (HCV)","volume":"207","author":"Masoud","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4254\/wjh.v14.i1.1","article-title":"Hepatitis C virus: A critical approach to who really needs treatment","volume":"14","author":"Kouroumalis","year":"2022","journal-title":"World J. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/acsinfecdis.8b00081","article-title":"Virological Basis for the Cure of Chronic Hepatitis B","volume":"5","author":"Hu","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jhep.2018.11.030","article-title":"Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients","volume":"70","author":"Testoni","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"685706","DOI":"10.3389\/fonc.2021.685706","article-title":"HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies","volume":"11","author":"Cao","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1093\/infdis\/jiaa668","article-title":"Hepatitis B Vaccines","volume":"224","author":"Pattyn","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-0716-1892-9_8","article-title":"Developments in Vaccine Adjuvants","volume":"2412","author":"Firdaus","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e2067","DOI":"10.1093\/milmed\/usac389","article-title":"Preventing Hepatitis B Virus Infection Among U.S. Military Personnel: Potential Impact of a 2-Dose Versus 3-Dose Vaccine on Medical Readiness","volume":"188","author":"Oelschlager","year":"2022","journal-title":"Mil. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14218\/JCTH.2018.00037","article-title":"Hepatitis B Vaccine and Immunoglobulin: Key Concepts","volume":"7","author":"Das","year":"2019","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"903424","DOI":"10.3389\/fbioe.2022.903424","article-title":"A New Nano Adjuvant of PF3 Used for an Enhanced Hepatitis B Vaccine","volume":"10","author":"Shan","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"120674","DOI":"10.1016\/j.biomaterials.2021.120674","article-title":"Engineered therapeutic nanovaccine against chronic hepatitis B virus infection","volume":"269","author":"Qiao","year":"2021","journal-title":"Biomaterials"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"733364","DOI":"10.3389\/fimmu.2021.733364","article-title":"Interferon and Hepatitis B: Current and Future Perspectives","volume":"12","author":"Ye","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jconrel.2022.08.058","article-title":"Hepatocyte-targeted delivery of imiquimod reduces hepatitis B virus surface antigen","volume":"350","author":"Rouhollahi","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.medcli.2022.04.004","article-title":"Autoimmune hepatitis: Challenges and novelties","volume":"159","author":"Olivas","year":"2022","journal-title":"Med. Clin."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3350\/cmh.2020.0189","article-title":"Recent updates on the management of autoimmune hepatitis","volume":"27","author":"Komori","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.3748\/wjg.v23.i33.6030","article-title":"Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments","volume":"23","author":"Vergani","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"M33","DOI":"10.1530\/EJE-15-0464","article-title":"Cushing\u2019s syndrome: Update on signs, symptoms and biochemical screening","volume":"173","author":"Nieman","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1440-1746.2010.06579.x","article-title":"Treatment of autoimmune hepatitis: A review of current and evolving therapies","volume":"26","author":"Jothimani","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1021\/acsnano.8b09655","article-title":"Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model","volume":"13","author":"Violatto","year":"2019","journal-title":"ACS Nano"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"102497","DOI":"10.1016\/j.nano.2021.102497","article-title":"The mode of dexamethasone decoration influences avidin-nucleic-acid-nano-assembly organ biodistribution and in vivo drug persistence","volume":"40","author":"Ongaro","year":"2022","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9111","DOI":"10.1021\/acsnano.1c02391","article-title":"Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver","volume":"15","author":"Shen","year":"2021","journal-title":"ACS Nano"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/17425255.2019.1574744","article-title":"Hepatotoxicity induced by immune checkpoint inhibitors: A comprehensive review including current and alternative management strategies","volume":"15","author":"Jennings","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.sult.2016.08.003","article-title":"Hepatic Steatosis: Etiology, Patterns, and Quantification","volume":"37","author":"Idilman","year":"2016","journal-title":"Semin. Ultrasound CT MR"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial","volume":"385","author":"Loomba","year":"2015","journal-title":"Lancet"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Pouwels, S., Sakran, N., Graham, Y., Leal, A., Pintar, T., Yang, W., Kassir, R., Singhal, R., Mahawar, K., and Ramnarain, D. (2022). Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-00980-1"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"857956","DOI":"10.3389\/fphar.2022.857956","article-title":"Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2022.04.034","article-title":"Celastrol-loaded lactosylated albumin nanoparticles attenuate hepatic steatosis in non-alcoholic fatty liver disease","volume":"347","author":"Fan","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2174\/1568026622666220831092855","article-title":"Recent Advances of \u03b1-Glucosidase Inhibitors: A Comprehensive Review","volume":"22","author":"Agrawal","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"abf7311","DOI":"10.1126\/sciadv.abf7311","article-title":"Orally administered saccharide-sequestering nanocomplex to manage carbohydrate metabolism disorders","volume":"7","author":"Zhao","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep.29885","article-title":"Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2","volume":"68","author":"Lan","year":"2018","journal-title":"Hepatology"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Zanieri, F., Levi, A., Montefusco, D., Longato, L., De Chiara, F., Frenguelli, L., Omenetti, S., Andreola, F., Luong, T.V., and Massey, V. (2020). Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH. Cells, 9.","DOI":"10.3390\/cells9051237"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1007\/s11033-021-06269-1","article-title":"Liver sinusoidal endothelial cells are implicated in multiple fibrotic mechanisms","volume":"48","author":"Ma","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12565-017-0395-9","article-title":"The stellate cell system (vitamin A-storing cell system)","volume":"92","author":"Senoo","year":"2017","journal-title":"Anat. Sci. Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/smll.201402870","article-title":"The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension","volume":"11","author":"Duong","year":"2015","journal-title":"Small"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"G535","DOI":"10.1152\/ajpgi.00297.2005","article-title":"Defects in cGMP-PKG pathway contribute to impaired NO-dependent responses in hepatic stellate cells upon activation","volume":"290","author":"Perri","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/hepr.13040","article-title":"Vitamin A-coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis","volume":"48","author":"Furuhashi","year":"2018","journal-title":"Hepatol. Res."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Dewidar, B., Meyer, C., Dooley, S., and Meindl-Beinker, A.N. (2019). TGF-\u03b2 in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells, 8.","DOI":"10.3390\/cells8111419"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2018.05.032","article-title":"Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis","volume":"283","author":"Qiao","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.etap.2012.07.004","article-title":"Ameliorative effect of silibinin against N-nitrosodimethylamine-induced hepatic fibrosis in rats","volume":"34","author":"Ezhilarasan","year":"2012","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-0625.2007.00574.x","article-title":"RNAi-mediated inhibition of COL1A1 and COL3A1 in human skin fibroblasts","volume":"16","author":"Wang","year":"2007","journal-title":"Exp. Dermatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1021\/nn100589y","article-title":"Bioimaging for targeted delivery of hyaluronic Acid derivatives to the livers in cirrhotic mice using quantum dots","volume":"4","author":"Kim","year":"2010","journal-title":"ACS Nano"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"14029","DOI":"10.1021\/acsnano.2c03858","article-title":"Sequential Nano-Penetrators of Capillarized Liver Sinusoids and Extracellular Matrix Barriers for Liver Fibrosis Therapy","volume":"16","author":"Zhang","year":"2022","journal-title":"ACS Nano"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/adhm.201500826","article-title":"In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel Particles","volume":"4","author":"Kaps","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2016.12.006","article-title":"SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles","volume":"248","author":"Leber","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12951-021-01205-8","article-title":"Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma","volume":"20","author":"Yu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/liv.12247","article-title":"Relaxin decreases the severity of established hepatic fibrosis in mice","volume":"34","author":"Bennett","year":"2014","journal-title":"Liver Int."},{"key":"ref_101","first-page":"559","article-title":"Differential expression of transforming growth factor alpha, adhesions molecules and integrins in primary, metastatic liver tumors and in liver cirrhosis","volume":"15","author":"Jaskiewicz","year":"1995","journal-title":"Anticancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10585-007-9133-3","article-title":"Inhibition of the CXCR4\/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases","volume":"25","author":"Kim","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"21325","DOI":"10.1021\/acsomega.2c02683","article-title":"Functional cRGD-Conjugated Polymer Prodrug for Targeted Drug Delivery to Liver Cancer Cells","volume":"7","author":"Zhou","year":"2022","journal-title":"ACS Omega"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.7150\/thno.29101","article-title":"Theranostic Nanodots with Aggregation-Induced Emission Characteristic for Targeted and Image-Guided Photodynamic Therapy of Hepatocellular Carcinoma","volume":"9","author":"Gao","year":"2019","journal-title":"Theranostics"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/019262338701500112","article-title":"Endocytosis of asialo-glycoproteins and attachment to asialo-glycoproteins of hepatocytes from carcinogen-treated rats","volume":"15","author":"Schwarze","year":"1987","journal-title":"Toxicol. Pathol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2147\/DDDT.S166402","article-title":"Targeted and synergistic therapy for hepatocellular carcinoma: Monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib","volume":"12","author":"Duan","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Li, X., Wang, X., Liu, N., Wang, Q., and Hu, J. (2022). Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF\/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System. Molecules, 27.","DOI":"10.3390\/molecules27072082"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.actbio.2022.08.027","article-title":"N-acetyl-galactosamine modified metal-organic frameworks to inhibit the growth and pulmonary metastasis of liver cancer stem cells through targeted chemotherapy and starvation therapy","volume":"151","author":"Hu","year":"2022","journal-title":"Acta Biomater."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/cam4.1968","article-title":"CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line","volume":"8","author":"Asai","year":"2019","journal-title":"Cancer Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1016\/j.biomaterials.2012.03.067","article-title":"CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma","volume":"33","author":"Wang","year":"2012","journal-title":"Biomaterials"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1631\/jzus.B1900624","article-title":"Hyaluronic acid derivative-modified nano-structured lipid carrier for cancer targeting and therapy","volume":"21","author":"Liu","year":"2020","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Cannito, S., Bincoletto, V., Turato, C., Pontisso, P., Scupoli, M.T., Ailuno, G., Andreana, I., Stella, B., Arpicco, S., and Bocca, C. (2022). Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells. Molecules, 27.","DOI":"10.3390\/molecules27031062"},{"key":"ref_113","first-page":"527","article-title":"Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma","volume":"26","author":"Li","year":"2007","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"44123","DOI":"10.1038\/srep44123","article-title":"Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1149931","DOI":"10.3389\/fimmu.2023.1149931","article-title":"Role of CD147 in the development and diagnosis of hepatocellular carcinoma","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1021\/acsabm.1c00177","article-title":"CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells","volume":"4","author":"Tian","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"41107","DOI":"10.1021\/acsami.8b14972","article-title":"Actively Targeted Magnetothermally Responsive Nanocarriers\/Doxorubicin for Thermochemotherapy of Hepatoma","volume":"10","author":"Li","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1080\/21691401.2017.1360325","article-title":"Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab\u2019)2 and cell penetrating peptide for improved therapeutic effect on hepatocellular carcinoma","volume":"46","author":"Jin","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Komposch, K., and Sibilia, M. (2015). EGFR Signaling in Liver Diseases. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17010030"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1096\/fj.05-4058com","article-title":"Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Abdulmalek, S., Mostafa, N., Gomaa, M., El-Kersh, M., Elkady, A.I., and Balbaa, M. (2022). Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK\/ERK pathway. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0272776"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.7150\/thno.56882","article-title":"Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT","volume":"11","author":"Jia","year":"2021","journal-title":"Theranostics"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1021\/nn502074x","article-title":"pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma","volume":"8","author":"Ling","year":"2014","journal-title":"ACS Nano"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.yexcr.2014.04.005","article-title":"Therapeutic efficacy of improved \u03b1-fetoprotein promoter-mediated tBid delivered by folate-PEI600-cyclodextrin nanopolymer vector in hepatocellular carcinoma","volume":"324","author":"Hu","year":"2014","journal-title":"Exp. Cell Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"971475","DOI":"10.3389\/fonc.2022.971475","article-title":"Inhibitory of active dual cancer targeting 5-Fluorouracil nanoparticles on liver cancer in vitro and in vivo","volume":"12","author":"Cheng","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/acs.molpharmaceut.5b00677","article-title":"Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy","volume":"13","author":"Cai","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/0885328217713357","article-title":"Resveratrol-loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles: Preparation, characterization, and targeting effect on liver tumors","volume":"32","author":"Wu","year":"2017","journal-title":"J. Biomater. Appl."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"105036","DOI":"10.1016\/j.ejps.2019.105036","article-title":"Glycyrrhetinic acid-modified graphene oxide mediated siRNA delivery for enhanced liver-cancer targeting therapy","volume":"139","author":"Qu","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.2147\/IJN.S366180","article-title":"GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma","volume":"17","author":"Li","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e11130","DOI":"10.1097\/MD.0000000000011130","article-title":"Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.7150\/thno.40291","article-title":"Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment","volume":"10","author":"Ma","year":"2020","journal-title":"Theranostics"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"11124","DOI":"10.1080\/21655979.2021.2001239","article-title":"The transcatheter arterial chemoembolization combined with targeted nanoparticle delivering sorafenib system for the treatment of microvascular invasion of hepatocellular carcinoma","volume":"12","author":"Su","year":"2021","journal-title":"Bioengineered"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"16253","DOI":"10.18632\/oncotarget.3608","article-title":"Hepatoma-derived growth factor\/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijbiomac.2019.11.118","article-title":"Therapeutic applications of AS1411 aptamer, an update review","volume":"155","author":"Bayat","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1039\/D0RA10486H","article-title":"A dual-functional nanovehicle with fluorescent tracking and its targeted killing effects on hepatocellular carcinoma cells","volume":"11","author":"Zhang","year":"2021","journal-title":"RSC Adv."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/his.13847","article-title":"Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma","volume":"75","author":"Adachi","year":"2019","journal-title":"Histopathology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3109\/13880209.2012.761245","article-title":"Dual ligands modified double targeted nano-system for liver targeted gene delivery","volume":"51","author":"Jing","year":"2013","journal-title":"Pharm. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Meng, L., Yang, L., Zhao, X., Zhang, L., Zhu, H., Liu, C., and Tan, W. (2012). Targeted delivery of chemotherapy agents using a liver cancer-specific aptamer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033434"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1158\/1535-7163.MCT-07-2359","article-title":"Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery","volume":"7","author":"Lo","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.2147\/IJN.S272495","article-title":"In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice","volume":"15","author":"Ding","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"111399","DOI":"10.1016\/j.colsurfb.2020.111399","article-title":"SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivo","volume":"197","author":"Zhang","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_142","first-page":"1429","article-title":"Insulinlike growth factor-II\/mannose 6-phosphate receptor is expressed on CCl4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells","volume":"21","author":"Jannes","year":"1995","journal-title":"Hepatology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.510290526","article-title":"Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells","volume":"29","author":"Beljaars","year":"1999","journal-title":"Hepatology"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/jpet.111.179143","article-title":"Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice","volume":"337","author":"Prakash","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Van Beuge, M.M., Prakash, J., Lacombe, M., Post, E., Reker-Smit, C., Beljaars, L., and Poelstra, K. (2013). Enhanced effectivity of an ALK5-inhibitor after cell-specific delivery to hepatic stellate cells in mice with liver injury. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056442"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1126\/science.1136244","article-title":"A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A","volume":"315","author":"Kawaguchi","year":"2007","journal-title":"Science"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1042\/CBI20100321","article-title":"Hepatic stellate cell (vitamin A-storing cell) and its relative--past, present and future","volume":"34","author":"Senoo","year":"2010","journal-title":"Cell Biol. Int."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1021\/nn505166x","article-title":"Corona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapy","volume":"9","author":"Zhang","year":"2015","journal-title":"ACS Nano"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"122134","DOI":"10.1016\/j.biomaterials.2023.122134","article-title":"Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation","volume":"299","author":"Huang","year":"2023","journal-title":"Biomaterials"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1074\/jbc.275.17.12743","article-title":"Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor","volume":"275","author":"Beljaars","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"20739","DOI":"10.1021\/acsnano.2c07796","article-title":"Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis","volume":"16","author":"Hao","year":"2022","journal-title":"ACS Nano"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.2147\/IJN.S331690","article-title":"Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis","volume":"16","author":"Ashour","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_153","first-page":"785","article-title":"Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis","volume":"148","author":"Pinzani","year":"1996","journal-title":"Am. J. Pathol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0006-2952(03)00445-3","article-title":"The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue","volume":"66","author":"Beljaars","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1021\/mp200263q","article-title":"Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis","volume":"8","author":"Bansal","year":"2011","journal-title":"Mol. Pharm."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/jcmm.14097","article-title":"Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo","volume":"23","author":"Li","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-0716-3207-9_17","article-title":"Hepatic Stellate Cell Targeting Using Peptide-Modified Biologicals","volume":"2669","author":"Bansal","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"615599","DOI":"10.3389\/fmed.2020.615599","article-title":"Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis","volume":"7","author":"Gantzel","year":"2020","journal-title":"Front. Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.amsu.2015.09.001","article-title":"Anti-CD163-dexamethasone protects against apoptosis after ischemia\/reperfusion injuries in the rat liver","volume":"4","author":"Knudsen","year":"2015","journal-title":"Ann. Med. Surg."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.omtm.2016.11.004","article-title":"Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes","volume":"4","author":"Svendsen","year":"2017","journal-title":"Mol. Therapy. Methods Clin. Dev."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1093\/nar\/gkac308","article-title":"Targeted delivery to macrophages and dendritic cells by chemically modified mannose ligand-conjugated siRNA","volume":"50","author":"Uehara","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1039\/C9NR03374B","article-title":"Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy","volume":"11","author":"Wang","year":"2019","journal-title":"Nanoscale"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jconrel.2021.07.009","article-title":"Manipulation of TAMs functions to facilitate the immune therapy effects of immune checkpoint antibodies","volume":"336","author":"Liu","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/hep.21639","article-title":"The mannose receptor on murine liver sinusoidal endothelial cells is the main denatured collagen clearance receptor","volume":"45","author":"Malovic","year":"2007","journal-title":"Hepatology"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1021\/acsnano.9b01444","article-title":"Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model","volume":"13","author":"Liu","year":"2019","journal-title":"ACS Nano"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Xu, X., Wang, X., Liao, Y.P., Luo, L., Xia, T., and Nel, A.E. (2023). Use of a Liver-Targeting Immune-Tolerogenic mRNA Lipid Nanoparticle Platform to Treat Peanut-Induced Anaphylaxis by Single- and Multiple-Epitope Nucleotide Sequence Delivery. ACS Nano, in press.","DOI":"10.1021\/acsnano.2c12420"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"G71","DOI":"10.1152\/ajpgi.00215.2010","article-title":"Role of liver sinusoidal endothelial cells and stabilins in elimination of oxidized low-density lipoproteins","volume":"300","author":"Li","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"103337","DOI":"10.1016\/j.isci.2021.103337","article-title":"Stabilin receptors clear LPS and control systemic inflammation","volume":"24","author":"Cabral","year":"2021","journal-title":"iScience"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e2201095","DOI":"10.1002\/adma.202201095","article-title":"Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System","volume":"34","author":"Pattipeiluhu","year":"2022","journal-title":"Adv. Mater."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1021\/acsnano.8b03640","article-title":"Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery","volume":"12","author":"Paunovska","year":"2018","journal-title":"ACS Nano"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-017-0712-x","article-title":"The biology of Hepatocellular carcinoma: Implications for genomic and immune therapies","volume":"16","author":"Khemlina","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.celrep.2017.03.059","article-title":"Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells","volume":"19","author":"Tummala","year":"2017","journal-title":"Cell Rep."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and HCC: Trends, projections and risk factors","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10552-007-9067-8","article-title":"Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification","volume":"19","author":"Ishiguro","year":"2008","journal-title":"Cancer Causes Control"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1245\/s10434-007-9687-y","article-title":"Prognosis of perihilar cholangiocarcinoma: Hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus","volume":"15","author":"Sano","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: Current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"102017","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (Avastin\u00ae) in cancer treatment: A review of 15 years of clinical experience and future outlook","volume":"86","author":"Garcia","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S2468-1253(22)00043-7","article-title":"Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: An open-label, single-centre, phase 2 study","volume":"7","author":"Oh","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.suronc.2012.11.002","article-title":"A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases","volume":"22","author":"Slesser","year":"2013","journal-title":"Surg. Oncol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<612::AID-IJC17>3.0.CO;2-D","article-title":"Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis","volume":"71","author":"Brodt","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10585-007-9096-4","article-title":"Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis","volume":"25","author":"Gout","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/med.21738","article-title":"Targeting hepatocyte growth factor\/c-mesenchymal-epithelial transition factor axis in hepatocellular carcinoma: Rationale and therapeutic strategies","volume":"41","author":"Yu","year":"2021","journal-title":"Med. Res. Rev."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.20892\/j.issn.2095-3941.2022.0449","article-title":"Angiogenesis in hepatocellular carcinoma: Mechanisms and anti-angiogenic therapies","volume":"20","author":"Yao","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.21037\/tcr.2019.07.33","article-title":"IL-10 promoter hypomethylation is associated with increased IL-10 expression and poor survival in hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2019","journal-title":"Transl. Cancer Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1159\/000373976","article-title":"TGF-\u03b2 regulates hepatocellular carcinoma progression by inducing Treg cell polarization","volume":"35","author":"Shen","year":"2015","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/gastro\/goz060","article-title":"Antitumor immunity of low-dose cyclophosphamide: Changes in T cells and cytokines TGF-beta and IL-10 in mice with colon-cancer liver metastasis","volume":"8","author":"Huang","year":"2020","journal-title":"Gastroenterol. Rep."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne","year":"2022","journal-title":"Hepatology"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and Biology of Cancer-Associated Fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jcp.30582","article-title":"Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis","volume":"237","author":"Ezhilarasan","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2021.08.002","article-title":"The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-\u03b2 in CAF mediated tumor progression and therapeutic resistance","volume":"520","author":"Sarkar","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jtbi.2017.11.025","article-title":"Activation of the HGF\/c-Met axis in the tumor microenvironment: A multispecies model","volume":"439","author":"Konstorum","year":"2018","journal-title":"J. Theor. Biol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1158\/0008-5472.CAN-17-2268","article-title":"IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment","volume":"78","author":"Karakasheva","year":"2018","journal-title":"Cancer Res."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Kadomoto, S., Izumi, K., and Mizokami, A. (2021). Roles of CCL2-CCR2 Axis in the Tumor Microenvironment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168530"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3389\/fimmu.2019.01799","article-title":"Ontogeny of Tumor-Associated Macrophages","volume":"10","author":"Laviron","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.molimm.2019.11.014","article-title":"Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor","volume":"117","author":"Li","year":"2020","journal-title":"Mol. Immunol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"661323","DOI":"10.3389\/fimmu.2021.661323","article-title":"Tumor NLRP3-Derived IL-1\u03b2 Drives the IL-6\/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression","volume":"12","author":"Tengesdal","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Arvanitakis, K., Mitroulis, I., and Germanidis, G. (2021). Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy. Cancers, 13.","DOI":"10.3390\/cancers13122899"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.pathol.2019.06.001","article-title":"Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate","volume":"51","author":"Wiedemann","year":"2019","journal-title":"Pathology"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1166\/jbn.2019.2682","article-title":"Nano-Gold Loaded with Resveratrol Enhance the Anti-Hepatoma Effect of Resveratrol In Vitro and In Vivo","volume":"15","author":"Zhang","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.7150\/jca.30865","article-title":"Polymeric micelles loading with ursolic acid enhancing anti-tumor effect on hepatocellular carcinoma","volume":"10","author":"Zhou","year":"2019","journal-title":"J. Cancer"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.2147\/IJN.S193192","article-title":"In vitro and in vivo mechanism of hepatocellular carcinoma inhibition by \u03b2-TCP nanoparticles","volume":"14","author":"Liu","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"174512","DOI":"10.1016\/j.ejphar.2021.174512","article-title":"Strategies for active tumor targeting-an update","volume":"915","author":"Vyas","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Cheng, T.M., Chang, W.J., Chu, H.Y., De Luca, R., Pedersen, J.Z., Incerpi, S., Li, Z.L., Shih, Y.J., Lin, H.Y., and Wang, K. (2021). Nano-Strategies Targeting the Integrin \u03b1v\u03b23 Network for Cancer Therapy. Cells, 10.","DOI":"10.3390\/cells10071684"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/1541-7786.MCR-06-0286","article-title":"HAb18G\/CD147 functions in invasion and metastasis of hepatocellular carcinoma","volume":"5","author":"Xu","year":"2007","journal-title":"Mol. Cancer Res. MCR"},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Habault, J., and Poyet, J.L. (2019). Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies. Molecules, 24.","DOI":"10.3390\/molecules24050927"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1166\/jbn.2021.3014","article-title":"Oxaliplatin and Gedatolisib (PKI-587) Co-Loaded Hollow Polydopamine Nano-Shells with Simultaneous Upstream and Downstream Action to Re-Sensitize Drugs-Resistant Hepatocellular Carcinoma to Chemotherapy","volume":"17","author":"Zhang","year":"2021","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.2147\/IJN.S131078","article-title":"Polyethylene glycol-poly(\u03b5-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma","volume":"12","author":"Wang","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1080\/21691401.2018.1489266","article-title":"Gold nano-particles (AuNPs) carrying miR-326 targets PDK1\/AKT\/c-myc axis in hepatocellular carcinoma","volume":"47","author":"Mo","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"e142513","DOI":"10.1172\/jci.insight.142513","article-title":"PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells","volume":"6","author":"Salvioni","year":"2021","journal-title":"JCI Insight"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"188314","DOI":"10.1016\/j.bbcan.2019.188314","article-title":"Challenges in liver cancer and possible treatment approaches","volume":"1873","author":"Anwanwan","year":"2020","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/1381612826666200115095937","article-title":"Exploring Dysregulated Signaling Pathways in Cancer","volume":"26","author":"Nisar","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12951-020-00617-2","article-title":"Homotypic cell membrane-cloaked biomimetic nanocarrier for the accurate photothermal-chemotherapy treatment of recurrent hepatocellular carcinoma","volume":"18","author":"Sun","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/08853282221078107","article-title":"Injectable in situ intelligent thermo-responsive hydrogel with glycyrrhetinic acid-conjugated nano graphene oxide for chemo-photothermal therapy of malignant hepatocellular tumor","volume":"37","author":"Wang","year":"2022","journal-title":"J. Biomater. Appl."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"741305","DOI":"10.3389\/fimmu.2021.741305","article-title":"Tumor-Associated Macrophages and Their Functional Transformation in the Hypoxic Tumor Microenvironment","volume":"12","author":"He","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3389\/fimmu.2018.01591","article-title":"Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.2217\/fon-2017-0739","article-title":"Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments","volume":"14","author":"Petrillo","year":"2018","journal-title":"Future Oncol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"44407","DOI":"10.1021\/acsami.0c08473","article-title":"Nanoparticle Delivery of MnO2 and Antiangiogenic Therapy to Overcome Hypoxia-Driven Tumor Escape and Suppress Hepatocellular Carcinoma","volume":"12","author":"Chang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"101064","DOI":"10.1016\/j.nantod.2020.101064","article-title":"High-density lipoprotein modulates tumor-associated macrophage for chemoimmunotherapy of hepatocellular carcinoma","volume":"37","author":"Wang","year":"2021","journal-title":"Nano Today"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/cbdd.13166","article-title":"An overview on Vadimezan (DMXAA): The vascular disrupting agent","volume":"91","author":"Seidi","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_223","first-page":"CD011746","article-title":"Gemcitabine-based chemotherapy for advanced biliary tract carcinomas","volume":"4","author":"Elsayed","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"108944","DOI":"10.1016\/j.intimp.2022.108944","article-title":"ACT001 suppressing M1 polarization against inflammation via NF-\u03baB and STAT1 signaling pathways alleviates acute lung injury in mice","volume":"110","author":"Guo","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Boutilier, A.J., and Elsawa, S.F. (2021). Macrophage Polarization States in the Tumor Microenvironment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136995"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejpb.2022.07.002","article-title":"Co-delivery of Interleukin-12 and doxorubicin loaded Nano-delivery system for enhanced immunotherapy with polarization toward M1-type Macrophages","volume":"177","author":"Li","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Park, D.J., Sung, P.S., Lee, G.W., Cho, S., Kim, S.M., Kang, B.Y., Hur, W., Yang, H., Lee, S.K., and Lee, S.H. (2021). Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094710"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"107986","DOI":"10.1016\/j.pharmthera.2021.107986","article-title":"Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach","volume":"231","author":"Chamseddine","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Kuske, M., Haist, M., Jung, T., Grabbe, S., and Bros, M. (2022). Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?. Cancers, 14.","DOI":"10.3390\/cancers14071710"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ymthe.2022.09.012","article-title":"Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma","volume":"31","author":"Liu","year":"2023","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Liu, Q., Huang, W., Liang, W., and Ye, Q. (2023). Current Strategies for Modulating Tumor-Associated Macrophages with Biomaterials in Hepatocellular Carcinoma. Molecules, 28.","DOI":"10.3390\/molecules28052211"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","article-title":"KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: Behind the molecular mechanisms of statins","volume":"64","author":"Marrone","year":"2015","journal-title":"Gut"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2011.12.017","article-title":"Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats","volume":"142","author":"Xie","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1603451","DOI":"10.1002\/adma.201603451","article-title":"Targeting Nanocarriers with Anisamide: Fact or Artifact?","volume":"29","author":"Dasargyri","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1038\/s41467-019-10893-8","article-title":"Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy","volume":"10","author":"Hu","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Kaps, L., and Schuppan, D. (2020). Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers. Cells, 9.","DOI":"10.3390\/cells9092027"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.thorsurg.2018.12.001","article-title":"The Role of the Thymus in the Immune Response","volume":"29","author":"Thapa","year":"2019","journal-title":"Thorac. Surg. Clin."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00281-016-0583-z","article-title":"Dendritic cells as gatekeepers of tolerance","volume":"39","author":"Waisman","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"972121","DOI":"10.3389\/fimmu.2022.972121","article-title":"Genetic basis of defects in immune tolerance underlying the development of autoimmunity","volume":"13","author":"Hocking","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"616020","DOI":"10.3389\/fimmu.2020.616020","article-title":"Antigen-Presenting Cells in Food Tolerance and Allergy","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_241","first-page":"2","article-title":"Mechanisms of Allergen Immunotherapy in Allergic Rhinitis","volume":"21","author":"Layhadi","year":"2020","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"ltab009","DOI":"10.1093\/immadv\/ltab009","article-title":"Advancement of antigen-specific immunotherapy: Knowledge transfer between allergy and autoimmunity","volume":"1","author":"Richardson","year":"2021","journal-title":"Immunother. Adv."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/bs.ircmb.2019.10.003","article-title":"Ex vivo dendritic cell generation-A critical comparison of current approaches","volume":"349","author":"Han","year":"2019","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"109601","DOI":"10.1016\/j.intimp.2022.109601","article-title":"The role of tolerogenic dendritic cells in systematic lupus erythematosus progression and remission","volume":"115","author":"Mohammadi","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"889291","DOI":"10.3389\/fbioe.2022.889291","article-title":"Nanoparticle-Based Drug Delivery Systems for Induction of Tolerance and Treatment of Autoimmune Diseases","volume":"10","author":"Li","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2009.08.008","article-title":"Immune tolerance: What is unique about the liver","volume":"34","author":"Tiegs","year":"2010","journal-title":"J. Autoimmun."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jhep.2014.04.027","article-title":"TGF-\u03b2-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells","volume":"61","author":"Carambia","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jhep.2012.09.008","article-title":"Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells","volume":"58","author":"Carambia","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"16809","DOI":"10.1021\/jp8053636","article-title":"Hydrophilic Monodisperse Magnetic Nanoparticles Protected by an Amphiphilic Alternating Copolymer","volume":"112","author":"Shtykova","year":"2008","journal-title":"J. Phys. Chem. C Nanomater. Interfaces"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2015.01.006","article-title":"Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice","volume":"62","author":"Carambia","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/hep.22527","article-title":"Liver sinusoidal endothelial cells depend on mannose receptor-mediated recruitment of lysosomal enzymes for normal degradation capacity","volume":"48","author":"Elvevold","year":"2008","journal-title":"Hepatology"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.1073\/pnas.1408686111","article-title":"Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance","volume":"112","author":"Maldonado","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nnano.2016.135","article-title":"Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles","volume":"11","author":"Kishimoto","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"637469","DOI":"10.3389\/fimmu.2021.637469","article-title":"Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles","volume":"12","author":"Ilyinskii","year":"2021","journal-title":"Front. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/14\/11869\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:18:12Z","timestamp":1760127492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/14\/11869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":254,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["ijms241411869"],"URL":"https:\/\/doi.org\/10.3390\/ijms241411869","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]}}}